ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) Stock Price, Quote, News & History

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,789.66+0.42%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) Stock Price, Quote, News & History

ZLDAFOTCPK

Trade with Public

$0.2600

At close: Sep 25, 5:00 PM EST

OverviewNews Financials Sentiment Compare

Key Statistics

Open

Volume / Avg.

0 / 998.00

Day Range

- - -

52 Wk Range

0.20 - 0.42

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

4.49

Recent Zelira Therapeutics Ltd News

This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?

Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a leading player in cannabinoid medicine research, has successfully demonstrated that its proprietary drug for diabetic nerve pain, ZLT-L-007, surpasses the efficacy of Pfizer Inc. (NYSE:

Javier Hasse

Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment

Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder (ASD).

Joana Scopel

A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond

Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe at a dizzying rate.

Javier Hasse

Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama

By Franca Quarneti via El Planteo.

El Planteo

The Best Cannabis Conference In Latin America Arrives In Panama: Join LATAM CANN.BIZ On Sep. 1 & 2, Get Business Done

LatAm Cann.BIZ, the most important cannabis event in Latin America, will be held, on September 1 and 2, at the Santa María Luxury Collection Hotel & Golf Resort in Panama City.

Benzinga Cannabis

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

1.15M

Financing Cash Flow (TTM)

3.19M

Free Cash Flow (TTM)

-4.91M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-564.49K

Valuation Metrics

Enterprise Value

$4.91M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

6399.57

PB Ratio (TTM)

Earnings Yield % (TTM)

-86.41%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.24

Company Debt

Total Debt

$1.99M

LT Debt

LT Debt Issuance (TTM)

$3.19M

LT Debt Repayment (TTM)

Total Cash

$5.66K

Debt to Equity

Issuance of Debt (TTM)

$3.19M

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 998.00

Day Range

- - -

52 Wk Range

0.20 - 0.42

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

4.49

About

Sector

Health Care

Industry

Pharmaceuticals

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on inso...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) stock?

You can purchase shares of ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (OTCPK:ZLDAF) through any online brokerage.

View our list of the best stock brokerages

Who are ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) competitors?

There are no as such competitors for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd..

What is the forecast, or price target, for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) stock?

There is no analysis for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. to provide a consensus price target.

What is the current price for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF)?

The stock price for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (OTCPK: ZLDAF) is $0.26 last updated August 11, 2026 at 2:13 PM EDT.

Does ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) pay a dividend?

There are no upcoming dividends for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd..

When is ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (OTCPK:ZLDAF) reporting earnings?

ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. does not have any upcoming earnings scheduled.

Is ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) going to split?

There is no upcoming split for ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd..

What sector and industry does ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF) operate in?

ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.